Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 41, Issue 2, Pages 393-401
Publisher
Springer Nature
Online
2015-08-19
DOI
10.1038/npp.2015.251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gross morphological brain changes with chronic, heavy cannabis use
- (2015) Valentina Lorenzetti et al. BRITISH JOURNAL OF PSYCHIATRY
- Testing for Polygenic Effects in Genome-Wide Association Studies
- (2015) Wei Pan et al. GENETIC EPIDEMIOLOGY
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults
- (2015) B. J. Weiland et al. JOURNAL OF NEUROSCIENCE
- The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
- (2015) Rakesh Jetly et al. PSYCHONEUROENDOCRINOLOGY
- FAAH genetic variation enhances fronto-amygdala function in mouse and human
- (2015) Iva Dincheva et al. Nature Communications
- What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
- (2014) Wayne Hall ADDICTION
- The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
- (2014) Valentina Lorenzetti et al. CURRENT PHARMACEUTICAL DESIGN
- Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11
- (2014) Joseph Schuermeyer et al. DRUG AND ALCOHOL DEPENDENCE
- Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications
- (2014) Colin Cameron et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic predisposition to schizophrenia associated with increased use of cannabis
- (2014) R A Power et al. MOLECULAR PSYCHIATRY
- Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
- (2014) Nachshon Korem et al. NEUROPSYCHOPHARMACOLOGY
- Big Marijuana — Lessons from Big Tobacco
- (2014) Kimber P. Richter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study
- (2014) G. N. Giordano et al. PSYCHOLOGICAL MEDICINE
- The impact of substance use at psychosis onset on First Episode Psychosis course: Results from a 1 year follow-up study in Bologna
- (2014) Ilaria Tarricone et al. SCHIZOPHRENIA RESEARCH
- The effect of drug use on the age at onset of psychotic disorders in an Australian cohort
- (2014) Nikos C. Stefanis et al. SCHIZOPHRENIA RESEARCH
- Gone to Pot – A Review of the Association between Cannabis and Psychosis
- (2014) Rajiv Radhakrishnan et al. Frontiers in Psychiatry
- What can we learn about schizophrenia from studying the human model, drug-induced psychosis?
- (2013) Robin M. Murray et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Marijuana smokers at clinical high-risk for schizophrenia exhibit an enhanced subjective, behavioral and physiological response to smoked marijuana
- (2013) N.P. Vadhan et al. COMPREHENSIVE PSYCHIATRY
- CORTICO-LIMBIC RESPONSES TO MASKED AFFECTIVE FACES ACROSS PTSD, PANIC DISORDER, AND SPECIFIC PHOBIA
- (2013) William D. S. Killgore et al. DEPRESSION AND ANXIETY
- Factors associated with variability and stability of cannabis use in young adulthood
- (2013) Edmund Silins et al. DRUG AND ALCOHOL DEPENDENCE
- Avoidant symptoms in PTSD predict fear circuit activation during multimodal fear extinction
- (2013) Rebecca K. Sripada et al. Frontiers in Human Neuroscience
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
- (2013) Rebecca Kuepper et al. PLoS One
- Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
- (2013) Eti Ganon-Elazar et al. PSYCHONEUROENDOCRINOLOGY
- Cannabidiol enhances consolidation of explicit fear extinction in humans
- (2013) Ravi K. Das et al. PSYCHOPHARMACOLOGY
- Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
- (2013) M. Di Forti et al. SCHIZOPHRENIA BULLETIN
- A controlled family study of cannabis users with and without psychosis
- (2013) Ashley C. Proal et al. SCHIZOPHRENIA RESEARCH
- Targeting the endocannabinoid system to treat haunting traumatic memories
- (2013) Irit Akirav Frontiers in Behavioral Neuroscience
- The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)
- (2013) Viviana Trezza et al. Frontiers in Behavioral Neuroscience
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
- (2012) Torsten Passie et al. Drug Testing and Analysis
- Tobacco Use Before, At, and After First-Episode Psychosis
- (2012) Nicholas Myles et al. JOURNAL OF CLINICAL PSYCHIATRY
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
- A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers
- (2012) Rafael Mariano de Bitencourt et al. NEUROPHARMACOLOGY
- Cannabinoid facilitation of fear extinction memory recall in humans
- (2012) Christine A. Rabinak et al. NEUROPHARMACOLOGY
- Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory
- (2012) P. Atsak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis – 2012 Curt Richter Award Winner
- (2012) Rebecca M. Reynolds PSYCHONEUROENDOCRINOLOGY
- Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis
- (2012) Juan A. Galvez-Buccollini et al. SCHIZOPHRENIA RESEARCH
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
- (2012) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabis Use and Earlier Onset of Psychosis
- (2011) Matthew Large et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense Stress
- (2011) Eti Ganon-Elazar et al. NEUROPSYCHOPHARMACOLOGY
- Verbal learning and memory in adolescent cannabis users, alcohol users and non-users
- (2011) Nadia Solowij et al. PSYCHOPHARMACOLOGY
- Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization
- (2010) Daniel J. Foti et al. AMERICAN JOURNAL OF PSYCHIATRY
- Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects
- (2010) Ruud van Winkel ARCHIVES OF GENERAL PSYCHIATRY
- Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
- (2010) Daniel T Malone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Psychosis reactivity to cannabis use in daily life: an experience sampling study
- (2010) Cécile Henquet et al. BRITISH JOURNAL OF PSYCHIATRY
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
- (2010) Catalina Lopez-Quintero et al. DRUG AND ALCOHOL DEPENDENCE
- Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
- (2010) Molly K Larson et al. Expert Review of Neurotherapeutics
- Cannabis use disorders in schizophrenia: Effects on cognition and symptoms
- (2010) Pamela DeRosse et al. SCHIZOPHRENIA RESEARCH
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
- (2009) Fabrício A. Moreira et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
- (2009) Mohammed R. Milad et al. BIOLOGICAL PSYCHIATRY
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- (2009) George A. Fraser CNS Neuroscience & Therapeutics
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance
- (2009) E. Ganon-Elazar et al. JOURNAL OF NEUROSCIENCE
- Adverse health effects of non-medical cannabis use
- (2009) Wayne Hall et al. LANCET
- Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005
- (2009) Martin Frisher et al. SCHIZOPHRENIA RESEARCH
- Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
- (2008) Ahmad R. Hariri et al. BIOLOGICAL PSYCHIATRY
- Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
- (2008) Rafael M. Bitencourt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans
- (2008) K. L. Phan et al. JOURNAL OF NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started